Tirzepatide: A Dual-Acting Drug for Multiple Metabolic Conditions
Review of tirzepatide's dual GLP-1/GIP mechanism explores therapeutic prospects across diabetes, obesity, NASH, cardiovascular disease, and emerging indications.
Quick Facts
What This Study Found
Review of tirzepatide's dual GLP-1/GIP mechanism explores therapeutic prospects across diabetes, obesity, NASH, cardiovascular disease, and emerging indications.
Key Numbers
Review covers IRS-1 inhibition, microglial activation, and compromised GLP-1/GIP signaling as key AD mechanisms that tirzepatide might address.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide therapeutic knowledge.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Review of tirzepatide's dual GLP-1/GIP mechanism explores therapeutic prospects across diabetes, obe
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease.
- Published In:
- European journal of pharmacology, 1003, 177979 (2025)
- Authors:
- Alshehri, Ghadah H(2), Al-Kuraishy, Hayder M(3), Al-Gareeb, Ali I(3), Fawzy, Mohamed N, Waheed, Huda Jaber, Papadakis, Marios, Alexiou, Athanasios, El-Saber Batiha, Gaber
- Database ID:
- RPEP-09907
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review of tirzepatide's dual GLP-1/GIP mechanism explores therapeutic prospects across diabetes, obesity, NASH, cardiovascular disease, and emerging indications.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09907APA
Alshehri, Ghadah H; Al-Kuraishy, Hayder M; Al-Gareeb, Ali I; Fawzy, Mohamed N; Waheed, Huda Jaber; Papadakis, Marios; Alexiou, Athanasios; El-Saber Batiha, Gaber. (2025). A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease.. European journal of pharmacology, 1003, 177979. https://doi.org/10.1016/j.ejphar.2025.177979
MLA
Alshehri, Ghadah H, et al. "A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease.." European journal of pharmacology, 2025. https://doi.org/10.1016/j.ejphar.2025.177979
RethinkPeptides
RethinkPeptides Research Database. "A novel therapeutic prospect: a dual-acting tirzepatide for ..." RPEP-09907. Retrieved from https://rethinkpeptides.com/research/alshehri-2025-a-novel-therapeutic-prospect
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.